Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2018 Q1- Text added to 2018 Q2
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. freshman Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. freshman Avg
|
New words:
aforementioned, agonist, Alkem, Amneal, Annora, antagonist, ASR, bearing, County, DLBCL, Emcure, enrichment, Glenmark, humana, Kentucky, Lastly, led, lisocabtagene, Lycera, Mankind, maraleucel, MEDALIST, misrepresentation, MSN, negligent, nil, NOA, Pharmascience, Pike, Prinston, proceed, punitive, Racketeer, RADIANCE, rebuttal, remand, ROR, Sandoz, Saratoga, secondary, shareholder, Shilpa, SUNBEAM, thirty, Torrent, TRANSCEND, Transfusion, treble, Unichem, unjust, unlawful, Velianoski, Witchcoff
Removed:
albumin, bound, finite, jointly, penetration, plaque, psoriatic, separate, Stipulation, studied, UC, vigorously
Valuein 2018 Q1 filing- Value in 2018 Q2 filing
Original filings
Filing view